The global Alpers Disease Treatment Market Share is a critical, albeit niche, segment within the broader rare and neurological disease therapeutic areas. Alpers disease, also known as Alpers-Huttenlocher Syndrome (AHS), is a rare, progressive, and fatal neurodegenerative disorder predominantly affecting the brain and liver, caused by mutations in the POLG gene. This market overview p... https://www.databridgemarketresearch.com/reports/global-alpers-disease-treatment-market